A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to find out if ZW171 is safe and can treat participants with advanced (locally advanced \[inoperable\] and/or metastatic) mesothelin-expressing cancers.